Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil/uracil ratio
Thomas, F, Hennebelle, I, Delmas, C, Lochon, I, Dhelens, C, Garnier Tixidre, C, Bonadona, A, Penel, N, Goncalves, A, Delord, J P, Toulas, C, Chatelut, E
Published in Clinical pharmacology and therapeutics (01.02.2016)
Published in Clinical pharmacology and therapeutics (01.02.2016)
Get more information
Journal Article
Pharmacokinetics of heated intraperitoneal oxaliplatin
Ferron, G., Dattez, S., Gladieff, L., Delord, J.-P., Pierre, S., Lafont, T., Lochon, I., Chatelut, E.
Published in Cancer chemotherapy and pharmacology (01.09.2008)
Published in Cancer chemotherapy and pharmacology (01.09.2008)
Get full text
Journal Article
CPT-11 converting carboxylesterase and topoisomerase I activities in tumour and normal colon and liver tissues
GUICHARD, S, TERRET, C, HENNEBELLE, I, LOCHON, I, CHEVREAU, P, FRETIGNY, E, SELVES, J, CHATELUT, E, BUGAT, R, CANAL, P
Published in British Journal of Cancer (01.05.1999)
Published in British Journal of Cancer (01.05.1999)
Get full text
Journal Article
Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect
PUISSET, F, CHATELUT, E, SPARREBOOM, A, DELORD, J.-P, BERCHERY, D, LOCHON, I, LAFONT, T, ROCHE, H
Published in Cancer chemotherapy and pharmacology (01.07.2007)
Published in Cancer chemotherapy and pharmacology (01.07.2007)
Get full text
Journal Article
A phase I clinical and pharmacokinetic study of capecitabine (Xeloda ) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours
DELORD, J. P, PIERGA, J. Y, MERY-MIGNARD, D, CORNEN, X, MOURI, Z, BUGAT, R, DIERAS, V, BERTHEAULT-CVITKOVIC, F, TURPIN, F. L, LOKIEC, F, LOCHON, I, CHATELUT, E, CANAL, P, GUIMBAUD, R
Published in British journal of cancer (14.03.2005)
Published in British journal of cancer (14.03.2005)
Get full text
Journal Article
Impact of the biochemical assay for serum creatinine measurement on the individual carboplatin dosing: a prospective study
Léger, F., Séronie-Vivien, S., Makdessi, J., Lochon, I., Delord, J.P., Sarda, C., Canal, P., Chatelut, E.
Published in European journal of cancer (1990) (01.01.2002)
Published in European journal of cancer (1990) (01.01.2002)
Get full text
Journal Article
Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines
CALIARO, M. J, VITAUX, P, LAFON, C, LOCHON, I, NEHME, A, VALETTE, A, CANAL, P, BUGAT, R, JOZAN, S
Published in British journal of cancer (01.01.1997)
Published in British journal of cancer (01.01.1997)
Get full text
Journal Article
Relation between unbound plasma concentrations and toxicity in a prolonged oral etoposide schedule
PERDAEMS, N, BACHAUD, J. M, ROUZAUD, P, MURRIS-ESPIN, M, HERMANT, C, MIHURA, J, LOCHON, I, HOUIN, G, CANAL, P, CHATELUT, E
Published in European journal of clinical pharmacology (01.11.1998)
Published in European journal of clinical pharmacology (01.11.1998)
Get full text
Journal Article
Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia
Chalret du Rieu, Quentin, White-Koning, Mélanie, Picaud, Laetitia, Lochon, Isabelle, Marsili, Sabrina, Gladieff, Laurence, Chatelut, Etienne, Ferron, Gwenaël
Published in Cancer chemotherapy and pharmacology (01.09.2014)
Published in Cancer chemotherapy and pharmacology (01.09.2014)
Get full text
Journal Article
Dexamethasone as an in vivo probe for CYP3A metabolism: application to docetaxel and vinorelbine
Dalenc, F., Puisset, F., Cresteil, T., Lochon, I., Laffont, T., Hennebelle, I., Chevreau, C., Roché, H., Chatelut, E.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Population pharmacokinetics of total and unbound etoposide
NGUYEN, L, CHATELUT, E, CHEVREAU, C, TRANCHAND, B, LOCHON, I, BACHAUD, J.-M, PUJOL, A, HOUIN, G, BUGAT, R, CANAL, P
Published in Cancer chemotherapy and pharmacology (1998)
Get full text
Published in Cancer chemotherapy and pharmacology (1998)
Journal Article
Dihydropyrimidine dehydrogenase activity in normal, inflammatory and tumour tissues of colon and liver in humans
GUIMBAUD, R, GUICHARD, S, CANAL, P, DUSSEAU, C, BERTRAND, V, APARICIO, T, LOCHON, I, CHATELUT, E, COUTURIER, D, BUGAT, R, CHAUSSADE, S
Published in Cancer chemotherapy and pharmacology (2000)
Published in Cancer chemotherapy and pharmacology (2000)
Get full text
Journal Article
A limited-sampling strategy for estimation of etoposide pharmacokinetics in cancer patients
TRANCHAND, B, AMSELLEM, C, CHATELUT, E, FREYER, G, ILIADIS, A, LIGNEAU, B, TRILLET-LENOIR, V, CANAL, P, LOCHON, I, ARDIET, C. J
Published in Cancer chemotherapy and pharmacology (1999)
Published in Cancer chemotherapy and pharmacology (1999)
Get full text
Journal Article
CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissues
Guichard, S, Terret, C, Hennebelle, I, Lochon, I, Chevreau, P, Frétigny, E, Selves, J, Chatelut, E, Bugat, R, Canal, P
Published in British journal of cancer (01.05.1999)
Get full text
Published in British journal of cancer (01.05.1999)
Journal Article
Bayesian estimation of pharmacokinetic parameters of etoposide
Evene, E, Chatelut, E, Tranchand, B, Canal, P, Lochon, I, Iliadis, A, Ardiet, C J
Published in Bulletin du cancer (01.07.1997)
Get more information
Published in Bulletin du cancer (01.07.1997)
Journal Article
Relations between hematological toxicity and total and free plasma levels of etoposide in daily oral administration
Lavit, M, Chevreau, C, Chatelut, E, De Fenin, V, Lochon, I, Houin, G, Bugat, R, Canal, P
Published in Bulletin du cancer (01.08.1995)
Get more information
Published in Bulletin du cancer (01.08.1995)
Journal Article